Joint Corp
General ticker "JYNT" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $169.8M
Joint Corp follows the US Stock Market performance with the rate: 21.4%.
Estimated limits based on current volatility of 2.2%: low 10.10$, high 10.55$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [6.01$, 13.47$]
- 2024-12-30 to 2025-12-30 estimated range: [6.18$, 13.59$]
Financial Metrics affecting the JYNT estimates:
- Positive: 0.10 < Non-GAAP EPS, $ of 0.16
- Negative: Operating profit margin, % of -1.77 <= 1.03
- Negative: negative Net income
- Negative: 0 < Interest expense per share, $ of 0
- Positive: -0.96 < Investing cash flow per share, $ of -0.42
Short-term JYNT quotes
Long-term JYNT plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $79.98MM | $100.84MM | $115.06MM |
| Operating Expenses | $73.86MM | $100.01MM | $117.14MM |
| Operating Income | $6.13MM | $0.83MM | $-2.07MM |
| Non-Operating Income | $-0.07MM | $-0.13MM | $3.71MM |
| Interest Expense | $0.07MM | $0.95MM | $0.07MM |
| Income(Loss) | $6.06MM | $0.70MM | $1.64MM |
| Taxes | $-1.51MM | $0.07MM | $11.39MM |
| Profit(Loss) | $7.57MM | $0.63MM | $-9.75MM |
| Stockholders Equity | $30.28MM | $32.56MM | $24.75MM |
| Inventory | $1.38MM | $1.86MM | $0.00MM |
| Assets | $87.06MM | $93.49MM | $87.15MM |
| Operating Cash Flow | $13.84MM | $8.21MM | $14.68MM |
| Capital expenditure | $8.38MM | $8.77MM | $5.00MM |
| Investing Cash Flow | $-12.75MM | $-17.90MM | $-6.19MM |
| Financing Cash Flow | $-2.00MM | $0.33MM | $0.17MM |
| Earnings Per Share* | $0.46 | $0.08 | $-0.66 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.